Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Dec 2023 for POINT Biopharma Global Inc.. Read the official filing
Filing timeline
BuySaleJoe A. Mccann
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Joe A. Mccann: trading record in brief
Joe A. Mccann (chief executive) discloses dealings in POINT Biopharma Global Inc. to SEC (Form 4). In total, 4 filings cover trades dated from 30 June 2021 to 22 December 2023.
No open-market sale appears; the market trades are 1 purchase worth €14k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant.
The newest entry dates from 27 December 2023: a transaction, in POINT Biopharma Global Inc. The clock since the last published purchase (30 November 2022) now reads 1,418 days. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joe A. Mccann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,160 sharesCommon StockSEC:0001104659-23-129775:0
120,000 shares0Common StockSEC:0001104659-23-115375:0
2,160 shares@ US$6.64100.0% of flowCommon StockSEC:0001104659-22-123356:0
Canonical exit: 27 Feb 2023 (T+90)
3,614,153 sharesCommon StockSEC:0001104659-21-087832:0
4 of 4 declarations
